1. 3406 Receptor tyrosine kinase gene expression analyses of Ewing sarcomas identify ROR1 as a potential therapeutic target in metastatic disease. (September 2015) Authors: Berning, P.; Tillmanns, A.; Korsching, E.; Lechtape, B.; Schaefer, C.; Schleithoff, C.; schäfer, L.; Dirksen, U.; Potratz, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S690 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3407 Identification of novel EWS-FLI1 specific targets in Ewing sarcoma through pooled shRNA screens. (September 2015) Authors: Schaefer, C.; Berning, P.; Mallela, N.; Seggewiß, J.; Schleithoff, C.; Korsching, E.; Dirksen, U.; Potratz, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S691 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The CXCR4 antagonist Plerixafor (AMD3100) promotes Ewing sarcoma cell survival and migration in Ewing sarcoma cells in vitro. (December 2016) Authors: Dirksen, U.; Berning, P.; Schaefer, C.; Potratz, J. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗